ILMN

AVOID

Illumina Inc.

Health Care

3.99

PEGY ratio

Rank #419

Why This Matters

This stock appears overvalued relative to its growth and dividend yield. Modest projected growth of 7.5% annually.

ILMN trades at 29.8x earnings against 7.5% growth (no dividend) (PEGY 3.99). The valuation appears stretched relative to the available growth and income.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-06-02

Valuation

29.8x

P/E Ratio

Growth

7.5%

5yr EPS

Income

0.0%

Div Yield

PEGY Components

PEGY Score3.99

Denominator7.5%

EPS (TTM)$5.51

Market Data

Price$164.40

ExchangeNASDAQ

S&P 500Nasdaq 100

What Changed

PEGY Score

3.36→3.99(+0.63)

Rank

#408→#419(11 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only